tirzepatide approval history Zepbound (tirzepatide) FDA Tirzepatide: First Approval | Drugs

One of the biggest highlights for me is that I used to rely on gabapentin for bulging discs in my back

D., Mason, R

Khaleghi-Mehr M, Delshad A-A, Shafie-Damavandi S, Roghani M

Mean PHQ-9 scores at baseline were 2.7 for the tirzepatide group and 2.6 for the placebo group, indicating minimal or no depression symptoms

The numbers on these two syringes are not interchangeable

Risks and considerations for microdosing tirzepatide The following are risks and considerations for microdosing tirzepatide: Lack of clinical evidence and FDA approval Currently, microdosing tirzepatide is not recommended or approved by the FDA for managing weight or blood sugar levels